Full name
GRIFOLS POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GRIFOLS POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. SIEDMIOGRODZKA 9, 01-204 WARSZAWA
TAX ID5262746909
Rate company:
GRIFOLS POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5262746909
KRS0000191892
Share capital50,000.00 zł
address
UL. SIEDMIOGRODZKA 9, 01-204 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5262746909
REGON
015643114
KRS
0000191892
Legal form
limited liability company
Register Address
UL. SIEDMIOGRODZKA 9, 01-204 WARSZAWA
Date of registration in KRS
2004-01-30
Date of commencement of economic activity
2004-01-30
Act signature
WA.XIII NS-REJ.KRS/11218/24/823
Pkd codes
46.46.Z - Wholesale of pharmaceutical goods
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
Payer VAT status
Active
Vat list bank account(s)
PL29 1280 0003 0000 0030 1140 0031 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2018 | 2019 | 2020 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 1 | 0,5 | 1,6 | 196,4 |
EBITDA | -0,9 | 3,3 | 5 | 51,4 |
Short time liabilities | 6 | 5 | 10,4 | 106,1 |
Equity capital | 13,2 | 13,4 | 14,5 | 7,8 |
Operating profit (EBIT) | 1,2 | 0,7 | 1,8 | 147,5 |
Assets | 26,9 | 19,5 | 25,8 | 32,5 |
Net profit (loss) | 0,7 | 0,3 | 1 | 295,6 |
Cash | 2,4 | 1,5 | 1,9 | 26,5 |
Net income from sale | 32,1 | 34,2 | 34,6 | 1 |
Liabilities and provisions for liabilities | 13,7 | 6 | 11,3 | 87,8 |
Working assets | 20,1 | 11,8 | 15,3 | 29,7 |
Depreciation | -2,1 | 2,6 | 3,2 | 23,9 |
% | % | % | p.p. | |
Profitability of capital | 5,6 | 2 | 7,2 | 5,2 |
Equity capital to total assets | 49,1 | 69,1 | 56,2 | -12,9 |
Gross profit margin | 3,1 | 1,6 | 4,6 | 3 |
EBITDA Margin | -2,8 | 9,6 | 14,4 | 4,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 68 | 54 | 110 | 56 |
Current financial liquidity indicator | 3.073230028152466 | 2.010927677154541 | 1.3507059812545776 | -0,6 |
Net dept to EBITDA | -5.087612152099609 | 0.21071599423885345 | 0.7446892261505127 | 0,5 |
Financial statements
01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdf01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Report on payments to public administration
Download pdf01-01-2022 - 31-12-2022
Activity report
Download pdf01-01-2022 - 31-12-2022
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Consolidated annual financial statements
Download pdf01-01-2022 - 31-12-2022
Annual financial report
Download pdfShow more (4)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Eres Medical sp. z o.o.
Płouszowice Kolonia
Emprime sp. z o.o.
Sękocin Nowy
Red Med Poland Sp. z o.o.
Chorzów
ELŻBIETA STĘPNIAK
Szczecin
ADO-MED Sp. z o.o.
Świętochłowice